Literature DB >> 10959648

Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings.

T Heiskanen-Kosma1, M Korppi.   

Abstract

Whether serum C-reactive protein (CRP) can be used to distinguish bacterial from viral pneumonia was studied in 193 paediatric patients who were identified in a prospective, population-based study. The proportion of patients < 5 y of age was 51%, 53% of these and 12% of the older patients were treated in hospital. Pneumococcal aetiology of infection was studied in paired sera by antibody and immune-complex assays, and chlamydial, mycoplasmal and viral aetiologies by routine antibody assays. CRP concentration was measured by immunoturbidometry. Pneumococcal infection (mixed infections with other agents included) was present in 57 cases, mycoplasmal and/or chlamydial infection (pneumococcal infections excluded) in 43, and viral infection (pneumococcal, mycoplasmal and chlamydial infections excluded) in 29 cases. The mean CRP concentrations (95% confidence interval) in these groups were 26.8 mg/l (20.1-33.5 mg/l), 31.8 mg/l (20.5-33.1 mg/l) and 26.1 mg/l (19.1-33.1 mg/l), respectively, and 24.9 mg/l (18.8-31.0 mg/l) in patients with no aetiological findings. When CRP values were compared between the 2 diagnostic groups of pneumococcal infections (antibody and immune-complex positive) no difference was found. In infants < 12 months of age the mean CRP concentration was 14.6 mg/l, and in 11 (65%) of them it was unmeasurable (< 10 mg/l). No significant differences were seen between hospitalized patients and outpatients. In conclusion, CRP concentration had no significant association with the microbial aetiology of pneumonia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959648     DOI: 10.1080/003655400750044971

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  23 in total

1.  Use of laboratory tests in out-of-hours services in Norway.

Authors:  Ingrid Keilegavlen Rebnord; Hogne Sandvik; Steinar Hunskaar
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

Review 2.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

3.  Biomarkers for community-acquired pneumonia in the emergency department.

Authors:  Todd A Florin; Lilliam Ambroggio
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

4.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

5.  Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.

Authors:  Are Stuwitz Berg; Christopher Stephen Inchley; Hans Olav Fjaerli; Truls Michael Leegaard; Morten Lindbaek; Britt Nakstad
Journal:  Eur J Pediatr       Date:  2017-03-09       Impact factor: 3.183

Review 6.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

8.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19

9.  Population-based burden of pneumonia before school entry in Schleswig-Holstein, Germany.

Authors:  Josef A I Weigl; Hans M Bader; Achim Everding; Heinz J Schmitt
Journal:  Eur J Pediatr       Date:  2003-03-06       Impact factor: 3.183

Review 10.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.